GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $937,000 | -27.9% | 26,250 | -25.8% | 0.81% | -25.8% |
| Q4 2020 | $1,300,000 | -34.9% | 35,400 | -33.2% | 1.09% | -2.2% |
| Q3 2020 | $1,996,000 | -14.3% | 53,029 | -7.2% | 1.12% | -13.2% |
| Q2 2020 | $2,330,000 | -46.3% | 57,146 | -50.1% | 1.28% | -43.7% |
| Q1 2020 | $4,336,000 | -41.0% | 114,503 | -26.8% | 2.28% | -32.8% |
| Q4 2019 | $7,351,000 | +15.3% | 156,391 | +4.7% | 3.39% | +6.2% |
| Q3 2019 | $6,373,000 | -0.7% | 149,416 | -6.8% | 3.19% | +8.7% |
| Q2 2019 | $6,415,000 | -0.6% | 160,294 | +3.8% | 2.94% | -8.4% |
| Q1 2019 | $6,453,000 | +16.4% | 154,382 | +6.5% | 3.20% | +3.7% |
| Q4 2018 | $5,543,000 | +3.1% | 144,990 | +8.3% | 3.09% | +12.4% |
| Q3 2018 | $5,375,000 | +17.7% | 133,876 | +18.2% | 2.75% | +22.4% |
| Q2 2018 | $4,567,000 | +7.8% | 113,252 | +4.4% | 2.25% | +16.4% |
| Q1 2018 | $4,237,000 | – | 108,510 | – | 1.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |